Gilead Sciences Inc.'s Sovaldi was a real breakthrough in the fight against the chronic liver disease hepatitis C (HCV). The condition may show no...
While half the trick of investing is figuring out what the consensus thinks, the wisdom of crowds is a myth when it comes to the...
Pharmaceutical companies have been raising the price of prescription drugs at an alarming rate since 2010.
According to a new report...
Another possible deal between two of the world's top pharmaceutical companies was announced this week when Shire Plc. (Nasdaq: SHPG) made an...
Pharmaceutical stocks have crushed the broader markets in 2015.
The S&P Pharmaceuticals Select Industry Index has climbed 20.9%...
The world's top pharma companies bring in billions in revenue every year, sometimes from only a few products.
That's the case with each...
Two top pharmaceutical companies announced a merger this morning, continuing 2015's massive run of M&A activity.
Botox maker...
The pharmaceutical industry is one of the most profitable sectors in the world.
More than $978 billion was spent on prescription drugs...
The pharmaceutical industry saw record-setting M&A activity in the first quarter of 2015.
According to...
Two big pharma companies are in merger talks this week. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced Tuesday it's...
A sector of the pharmaceutical market known as "high-margin specialty drugs" is presenting us with the best pharmaceutical stocks to buy now....
Editor's Note: We're sharing this Private Briefing with you because it contains a pick that's put Bill's readers up as much as 444%...
Pharmaceutical stocks can plummet for myriad reasons: loss of funding, lawsuits, poor clinical trials.
It's a risky sector to get...
Antibiotic-resistant microorganisms are turning into a national medical nightmare, and the need for new, more effective...
Pharmaceutical stocks soar when their companies receive FDA approval. The key to investing in the pharmaceutical sector is research: you've got...
News out of the medical world is making a certain group of pharmaceutical companies among the most promising drug
Pharmaceutical and biotech mergers and acquisitions (M&A) is on track to hand us the best year for non-mega merger deals since 2010 - which...
